Filing Details
- Accession Number:
- 0001354488-16-006989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-14 11:08:21
- Reporting Period:
- 2016-03-01
- Filing Date:
- 2016-04-14
- Accepted Time:
- 2016-04-14 11:08:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1378624 | Cellular Biomedicine Group Inc. | CBMG | Biological Products, (No Disgnostic Substances) (2836) | 861032927 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1569980 | (William) Wei Cao | 19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-01 | 10,000 | $5.40 | 184,472 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-03-01 | 10,000 | $17.15 | 174,472 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non- Qualified Stock Option (right to buy) (2013 Plan) | Acquisiton | 2016-03-01 | 10,000 | $0.00 | 10,000 | $5.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
40,000 | 2023-09-30 | No | 4 | M | Direct |
Footnotes
- The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- The option vests according to the following schedule: 1/36th per month following the vesting commencement date of September 30, 2013.
- Due to a delay in communication with regard to the timing of the transactions reported herein, the total number of derivative securities of the issuer beneficially owned by the reporting person reported in his Form 4 filed on March 4, 2016 did not account for the change in derivative securities owned as a result of the transactions reported herein. As of the date of this report, the total number of derivative securities of the issuer beneficially owned by the reporting person under his 2013 non-qualified stock option plan is 32,500.